Jeff Yass’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding OBIO
Jeff Yass's OBIO Position: Q3 2026 in Review
Jeff Yass reduced its Orchestra BioMed (OBIO) stake by 20% in Q3 2026, selling an estimated $62.2K and leaving 52,823 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #10750.
Jeff Yass first reported a position in OBIO in Q3 2023 and has held it in 9 quarters since. The position peaked at $644K in Q4 2025. 91 funds tracked by Wall St. Rank hold OBIO as of Q3 2026.
- Jeff Yass held 52,823 shares of Orchestra BioMed worth $329K as of Q3 2026.
- Jeff Yass sold 12,981 Orchestra BioMed shares in Q3 2026, an estimated $62.2K.
- Orchestra BioMed made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #10750 holding.
- Jeff Yass first reported a position in Orchestra BioMed in Q3 2023 and has held it in 9 quarters since.
- Jeff Yass's Orchestra BioMed position peaked at $644K in Q4 2025.
- 91 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.